MedLearn Media Welcomes its New CEO, Tom Dolan

ST. PAUL, Minn. (PRWEB) November 17, 2021 — MedLearn Media, one of the country’s leading providers of
medical coding, documentation, regulatory and compliance education, news and solutions, announced today
that Tom Dolan has been appointed the company’s Chief Executive Officer (CEO).

Dolan possesses a 15-year management and leadership track record, including experience in the clinical field,
where he specialized in software and complementary products and services. Most recently, he was CEO at
RURO, Incorporated, where he drove the company’s transition to cloud services and led ISO 9001 certification
of its procedures and other strategic milestones. Other previous relevant roles include management and
leadership positions at Brooks Life Science and VUEMED, Inc.

During his tenure at RURO, Dolan served as Vice President of Sales, Chief Operating Officer and CEO; he
directed and managed the market-facing and operational portions of the company’s business-to-business
initiatives. In these positions, he was responsible for leading the company’s triple-digit revenue growth,
including rebranding and developing new product strategies, as well as establishing key partnerships with, and
sales to, large pharmaceutical firms, major hospital systems and clinic networks. Dolan’s international
successes include several multimillion-dollar contract awards and subsequent on-time solution deployments in
Europe and the Middle East, and the establishment of profitable satellite operations in China.

“Tom joins MedLearn as we continue to reinvent our portfolio and seek new ways to create value for our
customers,” said Mike Rogge, MedLearn founder and board Chairman. “His exceptional results in markets
similar to ours and his vision for value creation are both causing a lot of excitement. MedLearn is celebrating
30 years of operation. What a moment in our history this is!”

“The MedLearn portfolio, which includes coding, compliance and billing best practices guides, news services
and solutions, is unrivaled and owns a sterling reputation,” said Dolan. “I have spent my career focused on
modernizing offerings like these to be on-demand, “at-your-fingertips” resources, using the most current
delivery methods and market channels. This is a remarkable time in MedLearn’s history because the Company
has thrived for 30 years and, perhaps more remarkably, because its relevance continues to grow by the decade. I
am eager to continue MedLearn’s great legacy and broaden its impact on the field of human medicine.”

View the official press release here

Get More Insights